Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoTSE:4887 -0.93%53 Days Payable is 127.64 as of Mar. 2026, which is 13% below its 10-year median of 146.13. GuruFocus rates TSE:4887 with a GF Score™ of 53/100 and a GF Value™ of 円2,303.86 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 927 Drug Manufacturers companies, Sawai Group Holdings Co ranks better than 65.91% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sawai Group Holdings Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co (TSE:4887) has a Days Payable of 127.64 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sawai Group Holdings Co and its competitors. This is 13% below median its historical median of 146.13. Over the past decade, Sawai Group Holdings Co's Days Payable has ranged from 120.92 to 166.86. According to the industry distribution chart, Sawai Group Holdings Co ranks #316 out of 927 companies in the Drug Manufacturers industry, placing it in the top 34.1%.
Is Sawai Group Holdings Co's Days Payable too high?
Sawai Group Holdings Co's current Days Payable of 127.64 is 13% below median its 10-year median of 146.13. Over the past 10 years, this metric has ranged from a low of 120.92 to a high of 166.86. The Drug Manufacturers industry median Days Payable is 90.28. Sawai Group Holdings Co's value of 127.64 is 41.4% above this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #316 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sawai Group Holdings Co has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #316 out of 927 companies for Days Payable. This puts Sawai Group Holdings Co in the upper half of its industry. The industry median Days Payable is 90.28. Sawai Group Holdings Co's value of 127.64 is 41.4% above this benchmark. Historically, Sawai Group Holdings Co's own Days Payable has ranged from 120.92 to 166.86 over the past decade. While the company's 10-year median is 146.13 vs. the industry median of 90.28, Sawai Group Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.28, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current Days Payable of 127.64 is 41.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sawai Group Holdings Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current Days Payable is 127.64, which is 13% below median its own 10-year median of 146.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Sawai Group Holdings Co (TSE:4887) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,303.86, compared to a current price of 円1,601.50 — trading 30.5% below its estimated fair value. The current Days Payable is 127.64, which is 13% below median its 10-year median of 146.13 and 41.4% above the Drug Manufacturers industry median of 90.28. Sawai Group Holdings Co's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sawai Group Holdings Co (TSE:4887), the current Days Payable is 127.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (TSE:4887) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of 円1,601.50 is trading 30.5% below its estimated GF Value™ of 円2,303.86.
GuruFocus considers Sawai Group Holdings Co to be Significantly Undervalued.
Key valuation signals for TSE:4887:
Days Payable: 127.64 (13% below median its 10-year median of 146.13)
GF Value™: 円2,303.86 vs. price of 円1,601.50 (30.5% below fair value)
Industry Position: 41.4% above the Drug Manufacturers median (#316 of 927)
No single metric tells the full story. See the TSE:4887 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
53GF Score
Get the complete analysis for TSE:4887
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4887 has been successfully added to your 
